No Picture
News

Coherus BioSciences to Report First Quarter 2021 Financial Results on May 6th

REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that its first quarter 2021 financial results will be released after market close on Thursday, May 6, 2021. S… […]

No Picture
News

AnPac Bio Reports Fiscal Year 2020 Annual Financial Results (89.1% Increase in Revenue and 20.7% Decrease in Net Loss)

SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its annual financial… […]

No Picture
News

4D Molecular Therapeutics to Participate in BofA Securities 2021 Virtual Health Care Conference

EMERYVILLE, Calif., April 30, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced that management will present at the… […]

No Picture
News

New Cuff-Based Technology Monitors Endothelial Function to Aid Prevention, Treatment of Heart Disease

Berkeley Lab has developed a cuff-based technology to monitor both endothelial function and endothelium-independent vasodilation. Studies on human subjects have verified that the cuff-based method is 37% more sensitive to arterial relaxation than brach… […]

No Picture
News

Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

SOUTH SAN FRANCISCO, Calif., April 30, 2021 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other li… […]

No Picture
News

Genentech alum Jane Grogan goes startup hopping from ArsenalBio to Graphite Bio; Scott Holmes to handle CFO duties at Catamaran Bio, teaming up again with ex-Disarm CEO

Jane Grogan → Gene editing player Graphite Bio notched a $150 million Series B megaround to boost its total to $195 million, and a month later, Jane Grogan is moving from another startup to be Graphite’s CSO. Grogan is leaving ArsenalBio… […]

No Picture
News

Stanley Erck bagged $48M in pay as he guided Novavax on a remarkable turnaround in the hunt for a Covid-19 vaccine

Among the pandemic’s fly-by-night success stories, only Moderna rivals Maryland-based Novavax’s remarkable rise from the bowels of obscurity to vaccine player. Driving that change was CEO Stanley Erck, who helped build the biotech’s supply chain from s… […]